×

Reach More Sanofi Customers Where They Watch

Your customers are watching TV. Are you reaching them?

Sanofi missed 61% of its target audience in June 2025.

In June 2025, Sanofi spent $7.65 million on linear TV for Dupixent and reached only 38.7% of its target audience, about 7.1 million patients, at a cost of $1,078 per thousand. The campaign missed 61% of reachable viewers, leaving over 11 million potential patients untouched. In a market defined by awareness, these unseen patients represent a critical lost impact.

The Unseen Patients

Out of an 18 million strategic TV audience, only 7.1 million were reached. That leaves 10.9 million unserved, despite consistent TV engagement across the category. Each represents a missed opportunity to inform, reassure, and connect with qualified patients who are actively watching but remain unaware of Dupixent.

Your Competition isn’t Reaching Patients Either

Even competitors struggle with reach. Rinvoq reached just 31% of its target audience, leaving 69% of patients unreached. In categories where every brand is underexposed, the one that expands first beyond linear limitations earns lasting leadership in visibility and trust.

Maximize your patient reach with TV+

With TV+, Sanofi could grow patient reach by 24% at the same spend. By combining linear and connected TV, TV+ identifies undervalued audiences and reduces duplication, transforming 38.7% reach into scalable visibility. The outcome: stronger awareness, better efficiency, and measurable growth across every screen.

Ready to Reach More Customers?

See how TV+ can transform your pharma marketing with data-driven targeting and cross-channel optimization.

Let Simulmedia Help You Reach Your Audience

Discover how TV+ can maximize your customer reach with data-driven targeting and cross-channel optimization.

🔒 Your information is secure. We respect your privacy.